-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Celldex Initiates Global Registrational Phase 3 Program Of Barzolvolimab In Cold Urticaria And Symptomatic Dermographism

Reuters·12/09/2025 13:02:56

Please log in to view news